|
|
|
UBS Homepage >
Investor Relations >
Quarterly Reporting >
Balance Sheet
Balance Sheet  UBS's total assets stood at CHF 2,572.9 billion on 31 March 2007, up from CHF 2,396.5 billion on 31 December 2006. The increase
was driven by the growth in collateral trading (up CHF 85 billion), the trading portfolio (up CHF 59 billion), and the lending
portfolios (up CHF 30 billion), while positive replacement values grew moderately by CHF 2 billion. Currency movements against
the Swiss franc were immaterial in first quarter 2007. Total liabilities rose due to higher borrowing (up CHF 90 billion),
collateral trading liabilities (up CHF 44 billion), trading liabilities (up CHF 36 billion) and to a lesser extent due to
negative replacement values (up CHF
9 billion).
Lending and borrowing
Lending
Cash was CHF 3.8 billion on 31 March 2007, up slightly by CHF 0.3 billion from year-end 2006, mainly from higher sight deposit
balances held with central banks. Due from banks increased by CHF 6 billion, largely related to higher lending activities
by the cash and collateral trading business, which is the central funding instance of the bank. Our loans to customers stood
at CHF 332 billion on 31 March 2007, up by CHF 19 billion from 31 December 2006, reflecting higher secured lending volumes
for wealth management clients (in particular in Asia) and to a lesser extent continued growth in mortgages in Switzerland.
This was further accentuated by a substantial increase in the Investment Bank's secured lending to prime brokerage clients,
which was partially offset by lower secured lending balances to US mortgage originators as a result of the US mortgage securities
market slowdown.
Borrowing
Due to banks rose by CHF 16 billion to CHF 220 billion, mainly due to increased time deposits in the Investment Bank's cash
and collateral trading activities to accommodate the firm's general growth. Total debt issued (including financial liabilities
designated at fair value) increased to CHF 380 billion on 31 March 2007, up CHF 44 billion from year-end. Money market paper
issuance increased by CHF 20 billion, mainly in the US and Europe. The amount of long-term debt issued (including financial
liabilities designated at fair value) grew by CHF 24 billion to CHF 240 billion. Due to customers was up CHF 30 billion, mainly
reflecting larger time deposits from private clients in our wealth management franchise around the globe and to a lesser extent
in Switzerland from our retail banking business. Further growth was recorded in our Investment Bank's prime brokerage and
exchange traded derivative business.
Repo and securities borrowing / lending
In first quarter 2007, cash collateral on securities borrowed and reverse repurchase agreements increased by CHF 85 billion
or 11% to CHF 842 billion, while the sum of securities lent and repos grew by CHF 44 billion or 7% to CHF 653 billion. The
collateral trading asset increase stems primarily from the Investment Bank's matched book (a repo portfolio comprised of assets
and liabilities with equal maturities and equal value, so that the risks substantially cancel each other out) from a larger
fixed income book to cover an increase in short trading inventories and to a lesser extent from equity securities borrowing
activities. Repos and securities lending rose, largely to finance the growth in trading inventory.
Trading portfolio / derivative instruments
Between 31 December 2006 and 31 March 2007, trading assets increased by CHF 59 billion, reaching CHF 938 billion. Equity instruments
were up by CHF 22 billion, largely driven by higher volumes and accentuated by a slight rise in equity markets, while our
money market paper inventory (in particular European Commercial Paper) rose by CHF 20 billion, mainly in our fixed income,
rates and currencies business. Further, our traded loan portfolio grew by CHF 11 billion, related to securitization business,
while precious metals and debt instruments grew moderately (each up by CHF 3 billion). Over the same period, short trading
positions increased by CHF 36 billion to stand at CHF 241 billion. The positive replacement value of derivative instruments
increased CHF 2 billion to CHF 330 billion.
Terms of Use | Privacy Statement
Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information. © UBS 1998-2009. All rights reserved.
|
|
|
 |